FirsthandHealth
medRxiv PreprintsInternational18 November 2026

Timing the Target: Exploring the Circadian Transcriptome of Biologic Therapies in Asthma.

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: Many of the immune pathways involved in asthma or in asthma treatment show circadian or diurnal variation. Understanding this variation can aid in biomarker discovery and/or therapy optimization. Objective: To evaluate if receptors, cytokines, and their pathways (n=46) targeted by currently approved biologics show significant diurnal rhythmicity and to identify their peak expression time. Methods: We used longitudinal bulk RNA sequencing datasets (discovery/replication cohorts: GSE113883 and GSE223613) and one microarray file (GSE39445) for cross-platform replication/validation. Fi
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.